Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation

Pinterest hits NYSE in $1.4bn IPO
Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.
Zoom crashes into public markets with $751m
Zoom is floating above its range in an IPO in which Qualcomm will make an immediate $30.6m return, while Salesforce is buying $100m of shares through a private placement.
Turning Point directs itself to $167m IPO
Eli Lilly and GSK-backed precision oncology drug developer Turning Point Therapeutics floated at the top of its range while expanding the number of shares it issued.
Jumia makes room for $196m in IPO
Africa-focused e-commerce company Jumia floated in the middle of its range, with more than half the shares being bought by existing corporate investors.
NGM energises itself with $107m IPO
The biopharmaceutical developer floated at the top of its range and will secure $65.9m from existing backer Merck & Co through a private placement.
Ruhnn shows influence with $125m IPO
Alibaba-backed social influencer network Ruhnn floated in the middle of its range in the US, with Weibo buying $8m of shares.
Precision Bio hits public markets with $126m
The Baxter and Amgen-backed genome editing technology developer floated in the middle of its range and is now valued at more than $780m.
Tiger Brokers catches $104m in IPO
The Xiaomi-backed online brokerage floated above its range while its other corporate investor, International Brokers, bought more than $13m of shares.

Other News

Shockwave makes stock market impact
Abiomed-backed Shockwave Medical has raised approximately $97m in an oversubscribed initial public offering, before its shares climbed more than 85% by the end of Friday.
Futu brokers $90m IPO
Tencent invested $8m as the Chinese online brokerage floated at the top of its range in the US, at a valuation of more than $1.3bn.
CStone achieves $285m IPO
Taikang and WuXi-backed CStone Pharmaceuticals has priced its shares near the middle of its proposed range to raise $285m in proceeds at a valuation of $1.5bn.
Stealth Bio shifts to $78m IPO
Nan Fung-backed mitochondrial therapy developer Stealth BioTherapeutics floated at the foot of its range to raise $78m, having disclosed $100m in financing last June.
Harpoon snags public markets listing
The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.
Stealth to make stock market appearance
Nan Fung-backed biopharmaceutical company Stealth Bio has filed for an IPO that could bring in almost $87m if it floats at the top of the range.

Editor's Picks

Pinterest hits NYSE in $1.4bn IPO
Qualcomm-backed visual social media platform Pinterest floated above its range in an offering that will give it a market cap near $13bn.
Zoom crashes into public markets with $751m
Zoom is floating above its range in an IPO in which Qualcomm will make an immediate $30.6m return, while Salesforce is buying $100m of shares through a private placement.
IPO of the Year: DocuSign
A leading company in the e-signature and digital transaction management space, San Francisco-based DocuSign went public in April last year, with a market capitalization of $4.4bn.
Orchard IPO bears $200m of fruit
GSK, Sphera Global and Medison-backed gene therapy developer Orchard Therapeutics raised $200m in an offering that could possibly close at $230m.
test reg

Login